Vanja Sikirica

Vanja Sikirica is affiliated with Moderna Therapeutics in Cambridge, United States, where she applies expertise in health economics, outcomes research, and epidemiology developed through prior leadership roles at Shire Pharmaceuticals. She holds a Pharm.D. from the University of Maryland Baltimore (1999–2003), completed a fellowship in epidemiologic and statistics coursework at Jefferson Medical College of Thomas Jefferson University (2003–2005), and earned an MPH in Epidemiology, Statistics, and Health Finance and Management from The Johns Hopkins University (2007–2010). Her research focuses on real-world evidence and outcomes research, exemplified by her most-cited publication, "A systematic review of real-world evidence (RWE) supportive of new drug and biologic license application approvals in rare diseases" (2024), which has been cited 21 times. Her career reflects a sustained commitment to advancing evidence-based decision-making in pharmaceutical development and regulatory science.